Cytogenetic abnormalities and genomic copy number variations in EPO (7q22) and SEC-61(7p11) genes in primary myelodysplastic syndromes-Reference-Cited by-同舟云学术

Cytogenetic abnormalities and genomic copy number variations in EPO (7q22) and SEC-61(7p11) genes in primary myelodysplastic syndromes

Published:2016-07 Issue: Volume:59 Page:52-57
ISSN:1079-9796
Container-title:Blood Cells, Molecules, and Diseases
language:en
Short-container-title:Blood Cells, Molecules, and Diseases

Author:

Mohanty Purvi,Korgaonkar Seema,Shanmukhaiah Chandrakala,Ghosh Kanjaksha,Vundinti Babu Rao

Funder

Dept. of Atomic Energy (DAE)

Board of Research in Nuclear Sciences (BRNS)

Publisher

Elsevier BV

Subject

Cell Biology,Hematology,Molecular Biology,Molecular Medicine

Reference26 articles.

1. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients;Haase;Blood,2007

2. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes;Solé;Haematologica,2005

3. Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities;Pozdnyakova;Cancer,2008

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. Copy number variants, diseases and gene expression;Henrichsen;Hum. Mol. Genet.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alterations of the expression of TET2 and DNA 5-hmC predict poor prognosis in Myelodysplastic Neoplasms;BMC Cancer;2023-10-26

2. Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes;Scientific Reports;2022-04-08